Q2 2023 Cannara Biotech Inc Earnings Call Transcript
Greetings, and welcome to the Cannara Biotech investor presentation. (Operator Instructions) Please note that this conference is being recorded.
I will now turn the conference over to our host, Glen Akselrod, President, Bristol Capital. Thank you. You may begin.
Thank you, Diego, and thank you, everybody, for joining our webcast today with Cannara Biotech. The purpose of today's presentation is to give our audience a better understanding of the business through a PowerPoint presentation and then questions with management. The discussion is going to be led by Nicholas Sosiak, CFO. You should see the presentation in the webcast.
If you'd like, a copy of this PowerPoint, simply e-mail me at [email protected]. I'll be happy to send you one. We'll break for questions at the end of the formal presentation. When we do break, we encourage those questions. And as a reminder, we're only taking questions through the web portal.
If you're listening over the telephone, please access the web link that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |